Mednet Logo

What is the optimal treatment of medically inoperable T3N0 non-small cell lung cancer that is too large for standard SBRT?

Is standard chemoradiation the standard of care or conventional fractionation dose-escalated (>60 Gy) radiotherapy without chemotherapy or some form of hypofractionated radiotherapy?
Community PollStarted

How would you treat medically inoperable T3N0 NSCLC?

193 physicians have voted

Join Mednetto vote and see how they answered.

4 Answers
Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Quillen VA Medical Center
Answered on

As we see it, there is more than one way to skin the cat. RTOG 0617 has condemned protracted fractions to 70 Gy...it just might be that 70 Gy is the wrong way to treat in 35 fractions, +/- cetuximab added to weakly carbo taxol. But the study to look at thoracic dose is contaminated by those systemic...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Cleveland Clinic
Answered on · Updated on

update on 2/26/24:

I have been asked whether I have any updates to my comments of some years ago regarding the issue of SBRT for large inoperable T3N0 lung cancers. We have not changed our practice with respect to the SBRT component of our decision-making since as I noted, we have published on the ap...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Radiation Oncology · Radiation Medicine Associates
Answered on

Please read the preceding responses first as they are excellent. I wanted to add that there are 2 prospectively evaluated dose regimens that must be noted, particularly for patients going radiation alone without SABR.

The NCIC BR.25 treated patients to 60 Gy in 15 fx dose to isocenter with local cont...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · City of Hope
Answered on

Based on guidelines, the current standard for T3N0, IIB inoperable lung is probably chemoRT 60-66 Gy. I would not suggest going beyond 66 Gy as RTOG 0617 comparing 60 vs. 74 Gy for stage III disease showed inferior survival in the 74 Gy arm. In a fit patient, concurrent chemotherapy makes sense for ...

Join for free or sign in to see the full answer